Most Recent

image: Penetrating the Brain

Penetrating the Brain

By Megan Scudellari | November 1, 2013

Researchers use molecular keys, chisels, and crowbars to open the last great biochemical barricade in the body—the blood-brain barrier.

3 Comments

image: Remaking a Classic

Remaking a Classic

By Megan Scudellari | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

image: A Dime a Dozen

A Dime a Dozen

By Megan Scudellari | January 1, 2013

Affordable diagnostic tests tackle the world’s most pressing health problems.

0 Comments

image: Tumor Snipers

Tumor Snipers

By Megan Scudellari | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: The Little Cell That Could

The Little Cell That Could

By Megan Scudellari | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Treating Fat with Fat

Treating Fat with Fat

By Edyta Zielinska | May 1, 2012

Is brown fat ready for therapeutic prime time?

22 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By Megan Scudellari | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

image: New Tech Boosts Science

New Tech Boosts Science

By Tia Ghose | October 1, 2011

From iPhone apps to cloud computing, everyday digital technologies are helping advance drug discovery, conduct clinical trials, and improve medical care.

0 Comments

image: Make Mine Rare

Make Mine Rare

By Megan Scudellari | August 1, 2011

With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.

6 Comments

image: Take Two of These

Take Two of These

By Bob Grant | June 22, 2011

Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.

3 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Probiotics Prevent Cholera in Animal Models